These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
304 related items for PubMed ID: 12189490
1. Androgen receptor CAG polymorphism and prostate cancer risk. Mononen N, Ikonen T, Autio V, Rökman A, Matikainen MP, Tammela TL, Kallioniemi OP, Koivisto PA, Schleutker J. Hum Genet; 2002 Aug; 111(2):166-71. PubMed ID: 12189490 [Abstract] [Full Text] [Related]
2. Is reduced CAG repeat length in androgen receptor gene associated with risk of prostate cancer in Indian population? Mishra D, Thangaraj K, Mandhani A, Kumar A, Mittal R. Clin Genet; 2005 Jul; 68(1):55-60. PubMed ID: 15952987 [Abstract] [Full Text] [Related]
3. Polymorphic forms of prostate specific antigen and their interaction with androgen receptor trinucleotide repeats in prostate cancer. Binnie MC, Alexander FE, Heald C, Habib FK. Prostate; 2005 Jun 01; 63(4):309-15. PubMed ID: 15599941 [Abstract] [Full Text] [Related]
4. Polymorphic CAG/CAA repeat length in the AIB1/SRC-3 gene and prostate cancer risk: a population-based case-control study. Hsing AW, Chokkalingam AP, Gao YT, Wu G, Wang X, Deng J, Cheng J, Sesterhenn IA, Mostofi FK, Chiang T, Chen YL, Stanczyk FZ, Chang C. Cancer Epidemiol Biomarkers Prev; 2002 Apr 01; 11(4):337-41. PubMed ID: 11927493 [Abstract] [Full Text] [Related]
5. Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China. Hsing AW, Gao YT, Wu G, Wang X, Deng J, Chen YL, Sesterhenn IA, Mostofi FK, Benichou J, Chang C. Cancer Res; 2000 Sep 15; 60(18):5111-6. PubMed ID: 11016637 [Abstract] [Full Text] [Related]
6. [CAG microsatellite polymorphisms of androgen receptor gene and the stage and grade of prostate cancer]. Li C, Dong J, Guan W. Zhonghua Zhong Liu Za Zhi; 2001 May 15; 23(3):217-9. PubMed ID: 11783090 [Abstract] [Full Text] [Related]
7. Polymorphic CAG and GGC repeat lengths in the androgen receptor gene and prostate cancer risk: analysis of a Brazilian population. Silva Neto B, Koff WJ, Biolchi V, Brenner C, Biolo KD, Spritzer PM, Brum IS. Cancer Invest; 2008 Feb 15; 26(1):74-80. PubMed ID: 18181049 [Abstract] [Full Text] [Related]
8. CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer risk. Bratt O, Borg A, Kristoffersson U, Lundgren R, Zhang QX, Olsson H. Br J Cancer; 1999 Oct 15; 81(4):672-6. PubMed ID: 10574254 [Abstract] [Full Text] [Related]
9. Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk. Stanford JL, Just JJ, Gibbs M, Wicklund KG, Neal CL, Blumenstein BA, Ostrander EA. Cancer Res; 1997 Mar 15; 57(6):1194-8. PubMed ID: 9067292 [Abstract] [Full Text] [Related]
10. Significance of the CAG repeat polymorphism of the androgen receptor gene in prostate cancer progression. Nam RK, Elhaji Y, Krahn MD, Hakimi J, Ho M, Chu W, Sweet J, Trachtenberg J, Jewett MA, Narod SA. J Urol; 2000 Aug 15; 164(2):567-72. PubMed ID: 10893645 [Abstract] [Full Text] [Related]
11. Polymorphic repeats in the androgen receptor gene in high-risk sibships. Miller EA, Stanford JL, Hsu L, Noonan E, Ostrander EA. Prostate; 2001 Aug 01; 48(3):200-5. PubMed ID: 11494335 [Abstract] [Full Text] [Related]
12. Shorter CAG repeats in androgen receptor and non-GG genotypes in prostate-specific antigen loci are associated with decreased risk of benign prostatic hyperplasia and prostate cancer. Das K, Cheah PY, Lim PL, Zain YB, Stephanie FC, Zhao Y, Cheng C, Lau W. Cancer Lett; 2008 Sep 18; 268(2):340-7. PubMed ID: 18495332 [Abstract] [Full Text] [Related]
13. Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era. Platz EA, Leitzmann MF, Rifai N, Kantoff PW, Chen YC, Stampfer MJ, Willett WC, Giovannucci E. Cancer Epidemiol Biomarkers Prev; 2005 May 18; 14(5):1262-9. PubMed ID: 15894683 [Abstract] [Full Text] [Related]
14. The androgen receptor gene GGN microsatellite and prostate cancer risk. Platz EA, Giovannucci E, Dahl DM, Krithivas K, Hennekens CH, Brown M, Stampfer MJ, Kantoff PW. Cancer Epidemiol Biomarkers Prev; 1998 May 18; 7(5):379-84. PubMed ID: 9610786 [Abstract] [Full Text] [Related]
15. How strong is the association between CAG and GGN repeat length polymorphisms in the androgen receptor gene and prostate cancer risk? Zeegers MP, Kiemeney LA, Nieder AM, Ostrer H. Cancer Epidemiol Biomarkers Prev; 2004 Nov 18; 13(11 Pt 1):1765-71. PubMed ID: 15533905 [Abstract] [Full Text] [Related]
16. Difference between Swedish and Japanese men in the association between AR CAG repeats and prostate cancer suggesting a susceptibility-modifying locus overlapping the androgen receptor gene. Li C, Grönberg H, Matsuyama H, Weber G, Nordenskjöld M, Naito K, Bergh A, Bergerheim U, Damber JE, Larsson C, Ekman P. Int J Mol Med; 2003 Apr 18; 11(4):529-33. PubMed ID: 12632109 [Abstract] [Full Text] [Related]
17. Shorter CAG repeat length in the AR gene is associated with poor outcome in head and neck cancer. Rosa FE, dos Santos RM, Poli-Frederico RC, Canevari Rde A, Nishimoto IN, Magrin J, Rainho CA, Kowalski LP, Rogatto SR. Arch Oral Biol; 2007 Aug 18; 52(8):732-9. PubMed ID: 17321486 [Abstract] [Full Text] [Related]
18. A CAG repeat polymorphism in the androgen receptor gene is associated with reduced bone mass and increased risk of osteoporotic fractures. Langdahl BL, Stenkjaer L, Carstens M, Tofteng CL, Eriksen EF. Calcif Tissue Int; 2003 Sep 18; 73(3):237-43. PubMed ID: 14667136 [Abstract] [Full Text] [Related]
19. Androgen receptor polymorphisms and the incidence of prostate cancer. Chen C, Lamharzi N, Weiss NS, Etzioni R, Dightman DA, Barnett M, DiTommaso D, Goodman G. Cancer Epidemiol Biomarkers Prev; 2002 Oct 18; 11(10 Pt 1):1033-40. PubMed ID: 12376504 [Abstract] [Full Text] [Related]
20. The polymorphic exon 1 androgen receptor CAG repeat in men with a potential inherited predisposition to prostate cancer. Lange EM, Chen H, Brierley K, Livermore H, Wojno KJ, Langefeld CD, Lange K, Cooney KA. Cancer Epidemiol Biomarkers Prev; 2000 Apr 18; 9(4):439-42. PubMed ID: 10794490 [Abstract] [Full Text] [Related] Page: [Next] [New Search]